TSX-V:EMO - TSX Venture Exchange - CA29102L4064 - Common Stock - Currency: CAD
TTM (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 12.71M | 13.52M | 21.93M | 20.98M | 17.36M | |||
Research and Development | N/A | 9.38M | 16.47M | 9.60M | 1.78M | |||
Selling, General, and Administrative Expenses | 7.70M | 4.14M | 5.46M | 11.38M | 15.58M | |||
Operating Income | -12.71M | -13.52M | -21.93M | -20.98M | -17.36M | |||
Interest Income/Expense | -1.03M | 7.80K | 426.60K | 270.70K | 129.10K | |||
Other Income/Expense | N/A | N/A | 10.00K | N/A | N/A | |||
Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
Income Before Taxes | -13.74M | -13.52M | -21.49M | -20.71M | -17.23M | |||
Income Tax | N/A | -589.30K | N/A | N/A | N/A | |||
Net Income | -13.15M | -12.93M | -21.49M | -20.71M | -17.23M | |||
EBITDA | -12.53M | -13.36M | -21.90M | -20.96M | -17.36M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.05 | -0.05 | -0.10 | -0.11 | -0.13 | |||
Statistics |
All data in CAD